254 related articles for article (PubMed ID: 32672896)
1. Stable renal function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation.
Pedersen SJV; Monagel DA; Mammen C; Lewis VA; Guilcher GMT; Bruce AA
Pediatr Blood Cancer; 2020 Sep; 67(9):e28568. PubMed ID: 32672896
[TBL] [Abstract][Full Text] [Related]
2. Changes in renal function in long-term survivors of allogeneic hematopoietic stem-cell transplantation: single-center experience.
Kang SH; Park HS; Sun IO; Choi SR; Chung BH; Choi BS; Min CK; Do JY; Yang CW; Kim YS; Yoon KW; Park CW
Clin Nephrol; 2012 Mar; 77(3):225-30. PubMed ID: 22377254
[TBL] [Abstract][Full Text] [Related]
3. Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction.
Kersting S; Verdonck LF
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1312-6. PubMed ID: 18940687
[TBL] [Abstract][Full Text] [Related]
4. Favorable outcome of non-myeloablative allogeneic transplantation in adult patients with severe sickle cell disease: A single center experience of 200 patients.
Damlaj M; Alahmari B; Alaskar A; Alhejazi A; Alsadi H; Ahmed M; Alanazi T; Ahmed R; Alharbi A; Shehabeddine I; Alzaidi A; Alkhuraisat S; Mahassnah I; Alquraan H; Ballili M; Alzahrani M
Am J Hematol; 2024 Jun; 99(6):1023-1030. PubMed ID: 38488686
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease.
Inam Z; Tisdale JF; Leonard A
Expert Rev Hematol; 2023; 16(11):879-903. PubMed ID: 37800996
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing outcome and incidence of late complications in children who underwent allogeneic hematopoietic stem cell transplantation for hemoglobinopathy.
Khalil A; Zaidman I; Elhasid R; Peretz-Nahum M; Futerman B; Ben-Arush M
Pediatr Hematol Oncol; 2012 Nov; 29(8):694-703. PubMed ID: 23020512
[TBL] [Abstract][Full Text] [Related]
7. GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation.
Sakellari I; Barbouti A; Bamichas G; Mallouri D; Kaloyannidis P; Fragidis S; Batsis I; Apostolou C; Karpouza A; Yannaki E; Smias C; Sombolos K; Anagnostopoulos A
Bone Marrow Transplant; 2013 Oct; 48(10):1329-34. PubMed ID: 23584436
[TBL] [Abstract][Full Text] [Related]
8. Ovarian tissue cryopreservation for fertility preservation before hematopoietic stem cell transplantation in patients with sickle cell disease: safety, ovarian function follow-up, and results of ovarian tissue transplantation.
Missontsa MM; Bernaudin F; Fortin A; Dhédin N; Pondarré C; Yakouben K; Neven B; Castelle M; Cavazzana M; Lezeau H; Peycelon M; Paye-Jaouen A; Sroussi J; Diesch-Furlanetto T; Barraud-Lange V; Sarnacki S; Fahd M; Marchand I; Delcour C; Vexiau D; Arlet JB; Kamdem A; Arnaud C; Dalle JH; Poirot C
J Assist Reprod Genet; 2024 Apr; 41(4):1027-1034. PubMed ID: 38358434
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease.
Locatelli F; Pagliara D
Pediatr Blood Cancer; 2012 Aug; 59(2):372-6. PubMed ID: 22544533
[TBL] [Abstract][Full Text] [Related]
10. Reduction in vaso-occlusive events following stem cell transplantation in patients with sickle cell disease.
Leonard A; Furstenau D; Abraham A; Darbari DS; Nickel RS; Limerick E; Fitzhugh C; Hsieh M; Tisdale JF
Blood Adv; 2023 Jan; 7(2):227-234. PubMed ID: 36240296
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin.
Soni S; Gross TG; Rangarajan H; Baker KS; Sturm M; Rhodes M
Pediatr Blood Cancer; 2014 Sep; 61(9):1685-9. PubMed ID: 24740582
[TBL] [Abstract][Full Text] [Related]
12. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease.
Strocchio L; Zecca M; Comoli P; Mina T; Giorgiani G; Giraldi E; Vinti L; Merli P; Regazzi M; Locatelli F
Br J Haematol; 2015 Jun; 169(5):726-36. PubMed ID: 25818248
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
Yu ZP; Ding JH; Chen BA; Liu BC; Liu H; Li YF; Ding BH; Qian J
Chin J Cancer; 2010 Nov; 29(11):946-51. PubMed ID: 20979694
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of hypertension and abnormal kidney function in children with sickle cell disease -a cross sectional review.
Bodas P; Huang A; O'Riordan MA; Sedor JR; Dell KM
BMC Nephrol; 2013 Oct; 14():237. PubMed ID: 24168027
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of acute and chronic renal function in children following matched related donor hematopoietic stem cell transplantation.
Ileri T; Ertem M; Ozcakar ZB; Ince EU; Biyikli Z; Uysal Z; Ekim M; Yalcinkaya F
Pediatr Transplant; 2010 Feb; 14(1):138-44. PubMed ID: 19413721
[TBL] [Abstract][Full Text] [Related]
16. Current attitudes of parents and patients toward hematopoietic stem cell transplantation for sickle cell anemia.
Meier ER; Dioguardi JV; Kamani N
Pediatr Blood Cancer; 2015 Jul; 62(7):1277-84. PubMed ID: 25809231
[TBL] [Abstract][Full Text] [Related]
17. Potential Risk Factors Associated With Graft Failure of Haploidentical Hematopoietic Stem Cell Transplantation in Children With Sickle Cell Disease.
Yu J; Black V; Lamba J; Horn B
J Pediatr Hematol Oncol; 2021 May; 43(4):e583-e586. PubMed ID: 32604335
[TBL] [Abstract][Full Text] [Related]
18. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
Großekatthöfer M; Güclü ED; Lawitschka A; Matthes-Martin S; Mann G; Minkov M; Peters C; Seidel MG
Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
[TBL] [Abstract][Full Text] [Related]
19. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
[TBL] [Abstract][Full Text] [Related]
20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
